1. RNA Profiles of Circulating Tumor Cells and Extracellular Vesicles for Therapy Stratification of Metastatic Breast Cancer Patients
   Corinna Keup et al, 2018, Clinical Chemistry CrossRef
2. Targeted deep sequencing revealed variants in cell-free DNA of hormone receptor-positive metastatic breast cancer patients
   Corinna Keup et al, 2020, Cellular and Molecular Life Sciences CrossRef
3. Circulating tumor cells and breast cancer‑specific mutations in primary breast cancer
   Michal Mego et al, 2020, Molecular and Clinical Oncology CrossRef
4. The Prospect of Identifying Resistance Mechanisms for Castrate-Resistant Prostate Cancer Using Circulating Tumor Cells: Is Epithelial-to-Mesenchymal Transition a Key Player?
   Tanzila Khan et al, 2020, Prostate Cancer CrossRef
5. Phosphorylation of AKT and ERK1/2 and mutations of PIK3CA and PTEN are predictive of breast cancer cell sensitivity to everolimus in vitro
   Valentina Citi et al, 2018, Cancer Chemotherapy and Pharmacology CrossRef
6. Loss of PTEN Expression, PIK3CA Mutations, and Breast Cancer Survival in the Nurses’ Health Studies
   Tengteng Wang et al, 2022, Cancer Epidemiology, Biomarkers & Prevention CrossRef
7. Targeting PIK3CA Actionable Mutations in the Circulome: A Proof of Concept in Metastatic Breast Cancer
   Barbara Cardinali et al, 2022, International Journal of Molecular Sciences CrossRef
8. Lack of effective translational regulation of PLD expression and exosome biogenesis in triple-negative breast cancer cells
   Julian Gomez-Cambronero, 2018, Cancer and Metastasis Reviews CrossRef
9. New insights into the genomic landscape of meningiomas identified FGFR3 in a subset of patients with favorable prognoses
   Aysha AlSahlawi et al, 2019, Oncotarget CrossRef